The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hematologic Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hematologic Neoplasms


Psychiatry related information on Hematologic Neoplasms


High impact information on Hematologic Neoplasms


Chemical compound and disease context of Hematologic Neoplasms


Biological context of Hematologic Neoplasms


Anatomical context of Hematologic Neoplasms


Gene context of Hematologic Neoplasms


Analytical, diagnostic and therapeutic context of Hematologic Neoplasms


  1. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. Hayes, R.B., Yin, S.N., Dosemeci, M., Li, G.L., Wacholder, S., Travis, L.B., Li, C.Y., Rothman, N., Hoover, R.N., Linet, M.S. J. Natl. Cancer Inst. (1997) [Pubmed]
  2. Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Doronina, S.O., Toki, B.E., Torgov, M.Y., Mendelsohn, B.A., Cerveny, C.G., Chace, D.F., DeBlanc, R.L., Gearing, R.P., Bovee, T.D., Siegall, C.B., Francisco, J.A., Wahl, A.F., Meyer, D.L., Senter, P.D. Nat. Biotechnol. (2003) [Pubmed]
  3. Cardiorespiratory toxicity due to miconazole. Fainstein, V., Bodey, G.P. Ann. Intern. Med. (1980) [Pubmed]
  4. MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. Lowsky, R., Magliocco, A., Ichinohasama, R., Reitmair, A., Scott, S., Henry, M., Kadin, M.E., DeCoteau, J.F. Blood (2000) [Pubmed]
  5. Toxicity and immunomodulatory effects of interleukin-2 after autologous bone marrow transplantation for hematologic malignancies. Higuchi, C.M., Thompson, J.A., Petersen, F.B., Buckner, C.D., Fefer, A. Blood (1991) [Pubmed]
  6. Conjunction dysfunction: CBP/p300 in human disease. Giles, R.H., Peters, D.J., Breuning, M.H. Trends Genet. (1998) [Pubmed]
  7. Music therapy for mood disturbance during hospitalization for autologous stem cell transplantation: a randomized controlled trial. Cassileth, B.R., Vickers, A.J., Magill, L.A. Cancer (2003) [Pubmed]
  8. Chromosome changes in hematologic malignancies. Larson, R.A., Golomb, H.M., Rowley, J.D. CA: a cancer journal for clinicians. (1981) [Pubmed]
  9. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Kung, A.L., Rebel, V.I., Bronson, R.T., Ch'ng, L.E., Sieff, C.A., Livingston, D.M., Yao, T.P. Genes Dev. (2000) [Pubmed]
  10. Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Packham, G., White, E.L., Eischen, C.M., Yang, H., Parganas, E., Ihle, J.N., Grillot, D.A., Zambetti, G.P., Nuñez, G., Cleveland, J.L. Genes Dev. (1998) [Pubmed]
  11. Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage. Harder, K.W., Parsons, L.M., Armes, J., Evans, N., Kountouri, N., Clark, R., Quilici, C., Grail, D., Hodgson, G.S., Dunn, A.R., Hibbs, M.L. Immunity (2001) [Pubmed]
  12. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J.C., Williams, I.R., Lee, C.K., Gerthner, R., Kitamura, T., Frantsve, J., Anastasiadou, E., Loh, M.L., Levy, D.E., Ihle, J.N., Gilliland, D.G. Mol. Cell (2000) [Pubmed]
  13. Evaluation of a radioimmunoassay for alpha 1-acid glycoprotein to monitor therapy of cancer patients. Ganz, P.A., Shell, W.E., Tökés, Z.A. J. Natl. Cancer Inst. (1983) [Pubmed]
  14. Re: Benzene and the dose-related incidence of hematologic neoplasms in China. Wong, O. J. Natl. Cancer Inst. (1998) [Pubmed]
  15. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group. Brown, R.A., Wolff, S.N., Fay, J.W., Pineiro, L., Collins, R.H., Lynch, J.P., Stevens, D., Greer, J., Herzig, R.H., Herzig, G.P. Blood (1995) [Pubmed]
  16. Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies. von Bueltzingsloewen, A., Belanger, R., Perreault, C., Bonny, Y., Roy, D.C., Lalonde, Y., Boileau, J., Kassis, J., Lavallee, R., Lacombe, M. Blood (1993) [Pubmed]
  17. Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Giaccone, L., McCune, J.S., Maris, M.B., Gooley, T.A., Sandmaier, B.M., Slattery, J.T., Cole, S., Nash, R.A., Storb, R.F., Georges, G.E. Blood (2005) [Pubmed]
  18. Farnesyltransferase inihibitors in hematologic malignancies. Harousseau, J.L. Blood Rev. (2007) [Pubmed]
  19. Expression of the 6C3 antigen on murine hematopoietic neoplasms. Association with expression of abl, ras, fes, src, erbB, and Cas NS-1 oncogenes but not with myc. Morse, H.C., Tidmarsh, G.F., Holmes, K.L., Frederickson, T.F., Hartley, J.N., Pierce, J.H., Langdon, W.Y., Dailey, M.O., Weissman, I.L. J. Exp. Med. (1987) [Pubmed]
  20. Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. Wlodarska, I., La Starza, R., Baens, M., Dierlamm, J., Uyttebroeck, A., Selleslag, D., Francine, A., Mecucci, C., Hagemeijer, A., Van den Berghe, H., Marynen, P. Blood (1998) [Pubmed]
  21. Mechanism of flt3 ligand expression in bone marrow failure: translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesis. Chklovskaia, E., Jansen, W., Nissen, C., Lyman, S.D., Rahner, C., Landmann, L., Wodnar-Filipowicz, A. Blood (1999) [Pubmed]
  22. Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Wang, Z., Zhang, Y., Liu, H., Salati, E., Chiriva-Internati, M., Lim, S.H. Blood (2003) [Pubmed]
  23. Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy. Gottlieb, D.J., Prentice, H.G., Heslop, H.E., Bello-Fernandez, C., Bianchi, A.C., Galazka, A.R., Brenner, M.K. Blood (1989) [Pubmed]
  24. Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. Schwaller, J., Koeffler, H.P., Niklaus, G., Loetscher, P., Nagel, S., Fey, M.F., Tobler, A. J. Clin. Invest. (1995) [Pubmed]
  25. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Finch, P.W., Rubin, J.S. Adv. Cancer Res. (2004) [Pubmed]
  26. The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes. Castrop, J., van Wichen, D., Koomans-Bitter, M., van de Wetering, M., de Weger, R., van Dongen, J., Clevers, H. Blood (1995) [Pubmed]
  27. Comparative evaluation of S9788, verapamil, and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies. Merlin, J.L., Guerci, A., Marchal, S., Missoum, N., Ramacci, C., Humbert, J.C., Tsuruo, T., Guerci, O. Blood (1994) [Pubmed]
  28. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Novak, A.J., Bram, R.J., Kay, N.E., Jelinek, D.F. Blood (2002) [Pubmed]
  29. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay. Ludescher, C., Hilbe, W., Eisterer, W., Preuss, E., Huber, C., Gotwald, M., Hofmann, J., Thaler, J. J. Natl. Cancer Inst. (1993) [Pubmed]
  30. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Yamamoto, Y., Kiyoi, H., Nakano, Y., Suzuki, R., Kodera, Y., Miyawaki, S., Asou, N., Kuriyama, K., Yagasaki, F., Shimazaki, C., Akiyama, H., Saito, K., Nishimura, M., Motoji, T., Shinagawa, K., Takeshita, A., Saito, H., Ueda, R., Ohno, R., Naoe, T. Blood (2001) [Pubmed]
  31. Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma. Kundu, M., Compton, S., Garrett-Beal, L., Stacy, T., Starost, M.F., Eckhaus, M., Speck, N.A., Liu, P.P. Blood (2005) [Pubmed]
  32. Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Höglund, M., Johansson, B., Pedersen-Bjergaard, J., Marynen, P., Mitelman, F. Blood (1996) [Pubmed]
  33. Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia. Buhl, A.M., Jurlander, J., Jørgensen, F.S., Ottesen, A.M., Cowland, J.B., Gjerdrum, L.M., Hansen, B.V., Leffers, H. Blood (2006) [Pubmed]
  34. Hematopoietic stem cell transplantation for cancer therapy. Reisner, Y., Segall, H. Curr. Opin. Immunol. (1995) [Pubmed]
  35. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E., Georges, G.E., Grumet, F.C., Kiem, H.P., Torok-Storb, B., Yu, C., Blume, K.G., Storb, R.F. Blood (2001) [Pubmed]
  36. Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Petz, L.D., Yam, P., Wallace, R.B., Stock, A.D., de Lange, G., Knowlton, R.G., Brown, V.A., Donis-Keller, H., Hill, L.R., Forman, S.J. Blood (1987) [Pubmed]
  37. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders. Maio, M., Pinto, A., Carbone, A., Zagonel, V., Gloghini, A., Marotta, G., Cirillo, D., Colombatti, A., Ferrara, F., Del Vecchio, L. Blood (1990) [Pubmed]
  38. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. Glasmacher, A., Prentice, A., Gorschlüter, M., Engelhart, S., Hahn, C., Djulbegovic, B., Schmidt-Wolf, I.G. J. Clin. Oncol. (2003) [Pubmed]
WikiGenes - Universities